Context Therapeutics Inc.

For the period ended Sep 30, 2026. Filed Nov 10, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 10, 2026

CNTX$0.19-6.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	September 30, 2026	December 31, 2025
	(Unaudited)	(Note 3)
Assets
Current assets:
Cash and cash equivalents	$34,410,919	$65,995,228
Prepaid expenses and other current assets	1,859,042	2,358,474
Total current assets	36,269,961	68,353,702
Property and equipment, net	66,599	29,656
Operating lease right-of-use asset	201,360	110,410
Total assets	$36,537,920	$68,493,768
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$1,595,274	$2,532,887
Accrued expenses and other current liabilities	3,730,866	5,375,090
Operating lease liability - current	175,087	112,064
Total current liabilities	5,501,227	8,020,041
Operating lease liability - non-current	31,435	—
Total liabilities	5,532,662	8,020,041
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding	—	—
Common stock, $0.001 par value; 300,000,000 and 200,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively; 91,879,177 shares issued and outstanding at September 30, 2026 and December 31, 2025	91,879	91,879
Additional paid-in capital	192,679,392	191,285,157
Accumulated deficit	(161,766,013)	(130,903,309)
Total stockholders' equity	31,005,258	60,473,727
Total liabilities and stockholders' equity	$36,537,920	$68,493,768

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.